Presentation TCT 2024 TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry Presenter: Aayush Singal October 29, 2024
Presentation TCT 2024 TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent Presenter: Michael Joner October 29, 2024
Presentation TCT 2024 TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials Presenter: Lei Song October 29, 2024
Presentation TCT 2024 TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center Presenter: Francesco Amata October 29, 2024
Presentation TCT 2024 TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting Presenter: KOTARO MIYASHITA October 29, 2024
Presentation TCT 2024 TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold Presenter: Ryan Wallace October 29, 2024
Presentation TCT 2024 TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes Presenter: Jiasheng Yin October 29, 2024
Presentation TCT 2024 TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry Presenter: Stefano Galli October 29, 2024
Presentation TCT 2024 TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease Presenter: Marta Mazur October 29, 2024
Presentation TCT 2024 TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy Presenter: Nancy Virginia October 29, 2024
Presentation TCT 2024 LIMUS as the Drug of Choice for Drug-Eluting Balloons Presenter: Aloke Finn October 29, 2024
Presentation TCT 2024 Evolution of PCI – Role and Value of Drug-Eluting Balloons Presenter: Roxana Mehran October 29, 2024
Presentation TCT 2024 Current and Future Clinical Evidence of SELUTION SLR™ DEB Presenter: Simon Eccleshall October 29, 2024
Presentation TCT 2024 TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial Presenter: Akihiro Tobe October 29, 2024
Presentation TCT 2024 TCT 454: Procedural Predictors of Optimal Angiographic Lesion Outcomes After Drug-Coated Balloon Treatment for De Novo Coronary Artery Disease Presenter: Dong Oh Kang October 29, 2024
Presentation TCT 2024 TCT 453: Comparison of “Predicted” Versus “Calculated” Flow Ratio (µFR) Acquired With Single-Angiografic View to Guide Drug-Coated Balloon Angioplasty in Coronary De-Novo Lesions Presenter: Stefano Galli October 29, 2024
Presentation TCT 2024 TCT 452: Angio-Based Quantitative Fractional Ratio After Drug-Coated Balloon for De Novo Coronary Lesions: Potential Role of Single View-Based Analysis Presenter: Stefano Galli October 29, 2024
Presentation TCT 2024 TCT 451: Plaque Changes and Vessel Remodeling After Balloon Angioplasty for De Novo Coronary Lesions Using Paclitaxel-Coated Balloons: A Serial IB-IVUS Study Presenter: Shelby Kerr October 29, 2024
Presentation TCT 2024 TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures Presenter: Simon Eccleshall October 29, 2024
News Conference News TCT 2024 DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF Caitlin E. Cox October 28, 2024